Research in Laura Marcu’s laboratory promotes better diagnosis, treatment, and prevention of human diseases through advancements in biophotonics technology – a field at the interface of physical sciences, engineering, biology, and medicine.
They have received their third National Institutes for Health grant for continuing work on the clinical applications of fluorescent lifetime imaging (FLIm) for diagnostic and surgical purposes.
Biomedical engineering Ph.D. student Hannah O'Toole was recently awarded a National Institutes of Health T32 Chemical Biology Program fellowship for her work in sensing biomarkers for cancerous tumors through biophotonics technology. "The whole idea of biophotonics is to use light to interrogate biological samples, typically to make some diagnostic observations," O'Toole explains.
